Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidade: FCF
Subjects: CARCINOGÊNESE ANIMAL, QUIMIOTERÁPICOS, RATOS (EXPERIMENTOS)
ABNT
PIERRI, Rodrigo de et al. The P53 pathway as a molecular target for the chemopreventive action of tributyrin in rat hepatocarcinogenesis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 abr. 2024. , 2010APA
Pierri, R. de, Horst, M. A., Conti, A. de, Heidor, R., Ortega, J. F., Ong, T. P., & Moreno, F. S. (2010). The P53 pathway as a molecular target for the chemopreventive action of tributyrin in rat hepatocarcinogenesis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Pierri R de, Horst MA, Conti A de, Heidor R, Ortega JF, Ong TP, Moreno FS. The P53 pathway as a molecular target for the chemopreventive action of tributyrin in rat hepatocarcinogenesis. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 70 res. FCF136.[citado 2024 abr. 18 ]Vancouver
Pierri R de, Horst MA, Conti A de, Heidor R, Ortega JF, Ong TP, Moreno FS. The P53 pathway as a molecular target for the chemopreventive action of tributyrin in rat hepatocarcinogenesis. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 70 res. FCF136.[citado 2024 abr. 18 ]